Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Presentations highlight ongoing research for ART Advanced Research Technologies Optix, SoftScan, and Fenestra products

ART Advanced Research Technologies Inc. ("ART") (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, will be featured in several scientific research presentations based on ART Advanced Research Technologies SoftScan optical imaging device, Optix® in vivo fluorescence optical imaging system, and Fenestra imaging agent for microCT, at the World Molecular Imaging Congress (WMIC), being held at the Palais des congrès in Montréal, Canada, from September 23 to 26, 2009.

Thursday, September 24, 2009 - 4:00 PM to 5:30 PM
Poster Presentation Number: 1088. Quantitative in vivo 3D fluorescence lifetime imaging of a liver-specific agent. G. Ma; D. Huang; M. Piché; M. Jean-Jacques; S.Fortier; M. Khayat.

Poster Presentation Number: 0300. Molecular imaging of pancreatic beta-cell mass: An antibody mediated optical imaging approach. D. Vats; F. Stuker; K. Dikaiou; H. Wang; H. Matile; C. Migliorini; M. Rudin.

Poster Presentation Number: 1215. Multimodal Molecular Imaging of Brain Cancer Using Nanoparticles Functionalized with IGFBP7 Single Domain Antibody. H. Albaghdadi; U. Iqbal; R. Mackenzie; D. Celine; T. Veres; D. Stanimirovic; B. Blasiak; B. Tomanek; G. Sutherland; A. Abulrob.

Poster Presentation Number: 1283. Exploring Novel Optical Imaging Methods for Quantifying Muscle Damage and Inflammation in Mouse Models of Muscular Dystrophy. A.R. Baudy; E. Hoffman; K. Nagaraju.
Poster Presentation Number: 1030. Early Detection of Metastasis Tumors in Mouse Liver Model Using Gated Small Animal FDG PET and Contrast CT Images. S. Woo; G. Cheon; K. Kim; T. Lee; J. Jung; Y. Lee; J. Kang; J. Park; J. Kim; J. Kim; S. Lim.
Poster Presentation Number: 0700. Liposome Contrast Agent for CT-based Detection and
Localization of Neoplastic and Inflammatory Lesions in Rabbits: Validation with FDG-PET and Histology. J. Zheng; C. Allen; D.C.Vines; S. Serra; M. Charron; D.A. Jaffray.

Friday, September 25, 2009 - 4:00 PM to 5:30 PM
Poster Presentation Number: 1119. Molecular Imaging using Nanotubes and a Clinical Optical Breast Imaging System. S.M. Van de Ven; N. Mincu; J. Brunette; G. Ma; M. Khayat; D.M. Ikeda; S.S. Gambhir.
Poster Presentation Number: 1005. Micro-CT small animal imaging enhanced by Fenestra LC and meglumine diatrizoate. S. Zhu; J. Tian; X. Ma; X. Zhang; G. Yan.
Poster Presentation Number: 1006. Negative Contrast Enhancement Enables Visualization of
Intraperitoneal Tumors in Mice Using CT. M. Rampurwala; M.K. Ravoori; W. Wei; V. Johnson; R. Vikram; V. Kundra.

Saturday, September 26, 2009
1:00 PM to 2:30 PM
Oral Presentation Number: 0217. Quantitative Dynamic SPECT/CT Imaging of Atherosclerotic Plaques in ApoE-/- Mice. B.M. Tsui; J. Yu; Y. Wang; G.S. Mok; S. Nimmagadda; D. Bedja; K.L. Gabrielson; F. Bengel; M. Pomper.
Oral Presentation Number: 0200. Replacing Vascular Corrosion Casting by in-vivo μCT Imaging for Building 3D Cardiovascular Models in Mice. B. Vandeghinste; B. Trachet; M. Renard; C. Casteleyn; S. Deleye; P. Joye; S. Vandenberghe; S.G. Staelens; P. Segers; B. Loeys.

4:00 PM to 5:30 PM
Poster Presentation Number: 0512. Whole-body fluorescence lifetime imaging of human melanoma metastases in mice using Green Fluorescence Protein (GFP). D. Huang; M. Piché; M. Jean-Jacques; G. Ma; M. Khayat.
Poster Presentation Number: 0511. Early detection of human breast cancer MCF-7 using anti-EpCAM antibody conjugated with Cy5.5. D. Huang; M. Piché; M. Jean-Jacques; G. Ma; M. Khayat.
Poster Presentation Number: 1268. Molecular Imaging of Brain Tumor Vessels Using Anti-IGFBP7 Single Domain Antibody Constructs. U. Iqbal; H. Albaghdadi; R. Mackenzie; B. Tomanek; G. Sutherland; D. Stanimirovic; A. Abulrob.
Poster Presentation Number: 0962. Multimodal therapeutic monitoring of HSV1-tk/GCV gene therapy using I-124-FIAU-PET, bioluminescence and liver contrast enhance CT in orthotopic hepatoma model. T. Lee; S. Woo; J. Jung; K. Woo; W. Chung; J. Kang; Y. Lee; K. Kim; G. Cheon; S. Lim.
Full texts of the abstracts can be obtained through the WMIC Itinerary Planner (http://wmicmeeting.org/dev/content/view/74/104/).

About ART Advanced Research Technologies

ART Advanced Research Technologies Inc. is a leader in molecular imaging products for the healthcare and pharmaceutical industries. ART Advanced Research Technologies has developed products in medical imaging, medical diagnostics, disease research, and drug discovery with the goal of bringing new and better treatments to patients faster. The Optix optical molecular imaging system, designed for monitoring physiological changes in living systems at the preclinical study phases of new drugs, is used by industry and academic leaders worldwide. The SoftScan® optical medical imaging device is designed to improve the diagnosis and treatment of breast cancer. Finally, the Fenestra line of molecular imaging contrast products provides image enhancement for a wide range of preclinical Micro CT applications allowing scientists to see greater detail in their imaging studies, with potential extension into other major imaging modalities. ART Advanced Research Technologies is commercializing some of these products in a global strategic alliance with GE Healthcare, a world leader in mammography and imaging. ART's shares are listed on the TSX under the ticker symbol ARA. For more information on ART Advanced Research Technologies , visit our website at www.art.ca.

Source: ART Advanced Research Technologies

You can discuss about ART Advanced Research Technologies and its Products & services in the ART Advanced Research Technologies Company User Group